editorial gsk plant for new anti hiv drug |
||||||||||||||||||||||||||||||||||||||||
| navigate by keyword : aids anti company drug editorial europe fostemsavir glaxosmithkline global gsk head healthcare hiv inauguration innovative italy majority new opens owned parma patients pfizer plant polo produce resistant san shareholders shionogi speaks specialist svp tim tordoff torrile treatment viiv |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| San Polo di Torrile, Italy - October 12, 2018: Tim Tordoff, SVP & Head of ViiV Europe, speaks at the inauguration of the plant to produce Fostemsavir, innovative anti-HIV drug |
||||||||||||||||||||||||||||||||||||||||
|
Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners. |
||||||||||||||||||||||||||||||||||||||||